AIMS/HYPOTHESIS: MODY (Maturity Onset Diabetes of the Young) is an autosomal dominant inherited type of diabetes with significant genetic heterogeneity. New mutations causing MODY are still being found. A genetically confirmed diagnosis of MODY allows application of individualized treatment based on the underlying concrete genetic dysfunction. Detection of novel MODY mutations helps provide a more complete picture of the possible MODY genotypes. MATERIALS AND METHODS: We tested 43 adult Czech patients with clinical characteristics of MODY, using direct sequencing of HNF1A (hepatocyte nuclear factor 1-alpha), HNF4A (hepatocyte nuclear factor 4-alpha) and GCK (glucokinase) genes. RESULTS: In three Czech families we identified three novel mutations we believe causing MODY-two missense mutations in HNF1A [F268L (c.802T>C) and P291S (c.871C>T)] and one frame shift mutation in GCK V244fsdelG (c.729delG). Some of the novel HNF1A mutation carriers were successfully transferred from insulin to gliclazide, while some of the novel GCK mutation carriers had a good clinical response when switched from insulin or oral antidiabetic drugs to diet. CONCLUSION: We describe three novel MODY mutations in three Czech families. The identification of MODY mutations had a meaningful impact on therapy on the mutation carriers.

3rd Faculty of Medicine of Charles University Centre of Research for Diabetes Endocrinological Diseases and Clinical Nutrition Ruská 87 100 00 Prague 10 Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc12025937

003      

CZ-PrNML

005      

20121212063512.0

007      

ta

008      

120817e20100204ie f 000 0#eng||

009      

AR

024    7_

$a 10.1016/j.diabres.2010.01.005 $2 doi

035    __

$a (PubMed)20132997

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a ie

100    0_

$a Bazalová, Zdenka. $7 _BN005313 $u 3rd Faculty of Medicine of Charles University, Centre of Research for Diabetes, Endocrinological Diseases and Clinical Nutrition, Ruská 87, 100 00 Prague 10, Czech Republic. bazalova@modydiabetes.cz

245    10

$a Three novel mutations in MODY and its phenotype in three different Czech families / $c Z. Bazalová, B. Rypácková, J. Broz, L. Brunerová, J. Polák, Z. Rusavý, L. Treslová, M. Andel,

520    9_

$a AIMS/HYPOTHESIS: MODY (Maturity Onset Diabetes of the Young) is an autosomal dominant inherited type of diabetes with significant genetic heterogeneity. New mutations causing MODY are still being found. A genetically confirmed diagnosis of MODY allows application of individualized treatment based on the underlying concrete genetic dysfunction. Detection of novel MODY mutations helps provide a more complete picture of the possible MODY genotypes. MATERIALS AND METHODS: We tested 43 adult Czech patients with clinical characteristics of MODY, using direct sequencing of HNF1A (hepatocyte nuclear factor 1-alpha), HNF4A (hepatocyte nuclear factor 4-alpha) and GCK (glucokinase) genes. RESULTS: In three Czech families we identified three novel mutations we believe causing MODY-two missense mutations in HNF1A [F268L (c.802T>C) and P291S (c.871C>T)] and one frame shift mutation in GCK V244fsdelG (c.729delG). Some of the novel HNF1A mutation carriers were successfully transferred from insulin to gliclazide, while some of the novel GCK mutation carriers had a good clinical response when switched from insulin or oral antidiabetic drugs to diet. CONCLUSION: We describe three novel MODY mutations in three Czech families. The identification of MODY mutations had a meaningful impact on therapy on the mutation carriers.

650    _2

$a diabetes mellitus $x farmakoterapie $x genetika $7 D003920

650    _2

$a dietoterapie $7 D004035

650    _2

$a zdraví rodiny $7 D005192

650    _2

$a gliklazid $x terapeutické užití $7 D005907

650    _2

$a glukokinasa $x genetika $7 D005941

650    _2

$a hepatocytární jaderný faktor 1-alfa $x genetika $7 D051538

650    _2

$a hepatocytární jaderný faktor 4 $x genetika $7 D051557

650    _2

$a lidé $7 D006801

650    _2

$a hypoglykemika $7 D007004

650    _2

$a inzulin $x terapeutické užití $7 D007328

650    _2

$a mutace $7 D009154

650    _2

$a rodokmen $7 D010375

650    _2

$a fenotyp $7 D010641

650    _2

$a výsledek terapie $7 D016896

651    _2

$a Československo $7 D003604

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Rypáčková, Blanka $7 xx0171714

700    1_

$a Brož, Jan, $d 1963- $7 xx0046397

700    1_

$a Brunerová, Ludmila $7 xx0106043

700    1_

$a Polák, J

700    1_

$a Rušavý, Zdeněk

700    1_

$a Trešlová, Ludmila, $d 1946- $7 xx0081995

700    1_

$a Anděl, Michal, $d 1946- $7 jn19981228006

773    0_

$w MED00001385 $t Diabetes research and clinical practice $x 1872-8227 $g Roč. 88, č. 2 (20100204), s. 132-8

856    41

$u https://pubmed.ncbi.nlm.nih.gov/20132997 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y m

990    __

$a 20120817 $b ABA008

991    __

$a 20121212063553 $b ABA008

999    __

$a ok $b bmc $g 947979 $s 783283

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2010 $b 88 $c 2 $d 132-8 $e 20100204 $i 1872-8227 $m Diabetes research and clinical practice $n Diabetes Res Clin Pract $x MED00001385

LZP    __

$a Pubmed-20120817/10/03